GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Affymax AFFY · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 2 Nov 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Affymax — daily AFFY Delayed
Market value
$29,958
Last close × shares
Volume
108
Shares, 2 Nov 2026

About Affymax

Its shares trade under the ticker AFFY. It has been listed since 15 December 2006. In the fiscal year to 31 December 2013, it reported revenue of $1.4m and a net loss of $14.4m. At that date it held total assets of $7.4m and shareholders' equity of −$1.4m.

Affymax, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York. The company went IPO on 2006-12-15. The Company’s product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells. The firm has a collaboration to develop and commercialize peginesatide with Takeda Pharmaceutical Company Limited. In March 2012, the Food and Drug Administration (FDA) approved the Company’s product, OMONTYS.

Figures and description from our data supplier, not checked against the company's own report.

More about Affymax →

Latest on Affymax

Our reporting

We have not reported on Affymax yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Affymax's ticker?

Affymax trades as AFFY on its US listing, under ISIN US00826A1097.

What was Affymax's last closing price?

0.00 on 2 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.